Envoy Medical Inc.

NASDAQ: COCH · Real-Time Price · USD
1.45
-0.03 (-2.03%)
At close: Aug 15, 2025, 9:54 AM

Envoy Medical Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
222K 212K 225K 278K 302K 297K 316K 241K 218K 214K 237K 217K 160K 101K n/a n/a n/a n/a
Cost of Revenue
804K 815K 742K 867K 869K 786K 808K 1.14M 1.05M 1.11M 1.15M 537K 431K 213K n/a n/a n/a n/a
Gross Profit
-582K -603K -517K -589K -567K -660K -663K -1.07M -1.01M -895K -910K -320K -271K -112K n/a n/a n/a n/a
Operating Income
-19.68M -19.46M -19.26M -21.47M -19.88M -19.5M -18.37M -14.54M -12.95M -10.67M -8.38M -6.44M -7.63M -6.51M -5.99M -5.02M -2.04M -966.7K
Interest Income
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 5.47K 20.84K 28.69K 28.69K 23.22K 7.84K
Pretax Income
-21.27M -19.52M -20.8M -21.06M -13.54M -22.83M -29.82M -36.41M -39.31M -27.3M -1.59M 5.17M 12.07M 13.68M -250.86K 4.47M -1.1M -1.47M
Net Income
-21.27M -19.52M -20.8M -21.06M -13.54M -22.83M -29.82M -36.41M -39.31M -27.3M -1.59M 5.17M 12.07M 13.68M -250.86K 4.47M -1.1M -1.47M
Selling & General & Admin
8.63M 8.29M 8.56M 10.15M 9.49M 9.63M 8.93M 6.73M 6.12M 4.57M 4.31M 3.94M 6.11M 6.51M 5.99M 5.02M 2.04M 966.98K
Research & Development
10.46M 10.57M 10.18M 10.76M 9.86M 9.42M 8.98M 7.37M 6.46M 5.67M 4.79M 3.34M 2.41M 1.05M n/a n/a n/a n/a
Other Expenses
n/a n/a n/a -36K -36K -8.8M -18.28M -26.82M -26.82M -18.05M -10.06M -1.49M -1.49M -1.49M n/a n/a n/a n/a
Operating Expenses
19.09M 18.86M 18.74M 20.88M 19.31M 19.01M 16.7M 12.47M 10.94M 8.59M 7.59M 6.23M 7.47M 6.51M 5.99M 5.02M 2.04M 966.98K
Interest Expense
1.77M 1.27M 816K 432K 168K 36K n/a n/a n/a n/a n/a n/a 5.47K 5.47K 5.47K 5.47K n/a n/a
Selling & Marketing Expenses
1.63M 1.77M 1.73M 1.73M 1.73M 1.62M 1.67M 1.15M 754K 371K 837K 837K 837K 837K n/a n/a n/a n/a
Cost & Expenses
19.9M 19.68M 19.48M 21.75M 20.18M 19.8M 17.33M 13.43M 11.81M 9.53M 8.94M 6.98M 8.11M 6.93M 5.99M 5.02M 2.04M 966.98K
Income Tax Expense
n/a n/a -9.28K -9.28K -9.28K 111.97K 121.25K 121.25K 121.25K n/a 13.95M 13.95M 13.9M 13.9M -54K -54K n/a n/a
Shares Outstanding (Basic)
21.38M 21.33M 21.33M 19.62M 19.6M 18.6M 19.6M 19.55M 19.55M 42.52M 53.13M 10.21M 53.13M 53.13M 53.13M 53.13M 53.13M 42M
Shares Outstanding (Diluted)
19.6M 21.33M 21.33M 19.62M 19.6M 18.6M 19.6M 19.55M 19.55M 42.52M 53.13M 11.21M 53.13M 53.13M 53.13M 53.13M 53.13M 42M
EPS (Basic)
-1.34 -1.29 -1.41 -1.3 -0.86 -1.27 -2.16 -2.13 -2.33 -1.82 -0.29 -0.16 0.07 0.25 -0.02 0.07 -0.03 -0.04
EPS (Diluted)
-1.34 -1.29 -1.41 -1.3 -0.86 -1.27 -2.16 -2.13 -2.32 -1.79 -0.26 -0.13 0.09 0.25 -0.02 0.07 -0.03 -0.04
EBITDA
-19.26M -18.05M -19.81M -22.31M -15.07M -15.78M -12.07M -8.26M -11.63M -9.33M -8.63M -10.47M -3.13M -577.86K -250.86K 4.47M -1.1M -1.47M
EBIT
-19.5M -18.25M -19.98M -22.48M -15.22M -24.65M -31.67M -27.84M -31.2M -20.15M -8.71M -10.52M -3.16M -590.86K -250.86K 4.47M -1.1M -1.47M
Depreciation & Amortization
243K 200K 173K 173K 153K 140K 133K 111K 104K 89K 75K 548.7K 9.09M 10.51M 10M 9.5M 938K -504K